Heartbeam Inc

10-Year Study

BEAT.US · Healthcare · US · Common Stock

Executive Summary: Heartbeam Inc has compounded at -22.6% annually over the last 10 years, with a maximum drawdown of 84.2% and an annualized volatility of 181.2%.

1Y CAGR
-34.7%
3Y CAGR
-21.7%
5Y CAGR
-22.6%
10Y CAGR
-22.6%

History & Riski10-year historical performance analysis including CAGR, Max Drawdown, Sharpe & Sortino ratios, annual returns, and rolling volatility — all computed from daily market data.

10-Year Growth of $10,000

Max DrawdownMax DrawdownThe largest peak-to-trough decline in the asset's value over the measurement period.Click for full definition →
84.2%
Sharpe RatioSharpe RatioRisk-adjusted return: how much excess return you earn per unit of total risk (volatility).Click for full definition →
0.38
Sortino RatioSortino RatioLike Sharpe, but only penalizes downside volatility — a more accurate risk measure for asymmetric return distributions.Click for full definition →
1.31
Ann. VolatilityAnnualized VolatilityThe annualized standard deviation of an asset's returns — a measure of how much prices fluctuate.Click for full definition →
161.4%
Best YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2022 · +58.4%
Worst YearBest & Worst YearThe single calendar year with the highest and lowest return in the measured period.Click for full definition →
2026 · -52.1%
% Positive Years% Positive YearsThe percentage of calendar years in the measurement period where the asset delivered a positive return.Click for full definition →
40%

Annual Returns

Rolling 12-Month Returns

Rolling 12-Month Annualised Volatility

Historical Drawdowns

Monthly Returns

Monthly Returns Heatmap

YearJanFebMarAprMayJunJulAugSepOctNovDecAnn.
2026-39.64.1-19.2-5.7————————-52.1%
20254.3-15.8-0.5-12.9-2.9-26.5-9.619.522.212.1-58.4211.74.3%
2024-20.4-22.550.3-7.838.3-7.61.6-10.0-1.34.326.4-24.8-2.1%
2023-20.7-10.3-34.6-0.44.02.626.1-31.32.9-42.316.962.1-51.8%
2022-29.5-19.45.4-25.75.8-11.09.3-9.2204.7-14.628.214.358.4%
2021———————————-13.7-13.7%

Risk X-RayiA 19-factor macroeconomic risk decomposition showing exactly which market forces (equity beta, rates, inflation, credit, commodity, crypto) drive this asset's volatility. Powered by multivariate regression against daily factor returns.

Risk Profile Insight: This asset has an estimated annualized volatility of 181.2%. The dominant macroeconomic risk driver is SHV.US, accounting for 33.0% of variance. Idiosyncratic stock-specific factors contribute 24.6%.

10-Year Historical Price Series (Growth of $10,000)
DateSimulated Value
2021-11-0110000
2021-12-018627.450980392157
2022-01-016078.43137254902
2022-02-014901.9607843137255
2022-03-015165.266106442577
2022-04-013837.5350140056025
2022-05-014061.624649859944
2022-06-013613.445378151261
2022-07-013949.579831932773
2022-08-013585.434173669468
2022-09-0110924.369747899162
2022-10-019327.731092436976
2022-11-0111960.78431372549
2022-12-0113669.467787114847
2023-01-0110840.336134453783
2023-02-019719.887955182074
2023-03-016358.543417366947
2023-04-016330.532212885154
2023-05-016582.63305322129
2023-06-016750.700280112045
2023-07-018515.406162464988
2023-08-015854.341736694678
2023-09-016022.408963585434
2023-10-013473.3893557422966
2023-11-014061.624649859944
2023-12-016582.63305322129
2024-01-015238.0952380952385
2024-02-014061.624649859944
2024-03-016106.442577030813
2024-04-015630.252100840336
2024-05-017787.114845938376
2024-06-017198.879551820728
2024-07-017310.924369747899
2024-08-016582.63305322129
2024-09-016498.5994397759105
2024-10-016778.711484593838
2024-11-018571.428571428572
2024-12-016442.577030812325
2025-01-016722.689075630253
2025-02-015658.263305322129
2025-03-015630.252100840336
2025-04-014901.9607843137255
2025-05-014761.904761904762
2025-06-013501.40056022409
2025-07-013165.266106442577
2025-08-013781.512605042017
2025-09-014621.848739495798
2025-10-015182.072829131653
2025-11-012156.8627450980393
2025-12-016722.689075630253
2026-01-014061.624649859944
2026-02-014229.6918767507
2026-03-013417.3669467787117
2026-04-013221.2885154061623
Annual Return Matrix
YearAnnual Return
20220.5844155844155843
2023-0.5184426229508197
2024-0.021276595744680993
20250.04347826086956519
2026-0.5208333333333334
Total Factor Risk
1.8116302918033902
VTI.US Exposure
0.1469498269963988
VEA.US Exposure
0.01228412502809788
VWO.US Exposure
-0.006209147958907427
QQQ.US Exposure
0.010630532189662496
VTV.US Exposure
0.023554851010768853
IJR.US Exposure
0.012237639779689802
QUAL.US Exposure
0.0012387791988193206
SHV.US Exposure
0.32994372543337985
TLT.US Exposure
0.01749892025537709
LQD.US Exposure
-0.0004053584001646571
HYG.US Exposure
0.02309296821697042
GLD.US Exposure
0.0223051211777339
USO.US Exposure
-0.0006390320686856174
VNQ.US Exposure
0.0006132439335295499
BTC-USD.CC Exposure
0.0016515270560045394
CPER.US Exposure
0.0005871449777406598
VIX.INDX Exposure
0.012571334842674581
UUP.US Exposure
0.000005331331691599057
TIP.US Exposure
0.146067476393224
Idiosyncratic Exposure
0.2460209906059942
Value Score
50
Growth Score
50
Profit Score
37.5
Health Score
23.6
Yield Score
0
Moat Score
40

Factor Risk Decomposition

Share of annualised volatility attributable to each macro factor.

Total Est. Vol
181.2%

FundamentalsiCompany financial health metrics: P/E valuation, dividend yield, Piotroski F-Score (9-point profitability signal), Altman Z-Score (bankruptcy risk proxy), and a radar chart across 6 fundamental dimensions. Note: ETFs may show N/A for some metrics.

Fundamental Dimensions

Core Valuation

P/E Ratio (TTM)P/E RatioPrice-to-Earnings ratio — the market price of a stock divided by its earnings per share, a key valuation measure.Click for full definition →N/A
Dividend YieldDividend YieldAnnual dividend paid per share divided by the current share price — expressed as a percentage income return.Click for full definition →0.00%
Market Cap$48.5M
Piotroski F-ScorePiotroski F-ScoreA 9-point scoring system evaluating a company's financial strength across profitability, leverage, and operating efficiency.Click for full definition →
9-point profitability signal
0.0/ 9
Weak
Altman Z-ScoreAltman Z-ScoreA bankruptcy prediction model that combines 5 financial ratios into a single score indicating financial distress risk.Click for full definition →
Bankruptcy risk proxy
1.18
Distress Zone
Income Simulation

Based on $10,000 initial investment.

Total Income Generated
$0
Avg Yield on Cost
0.00%

Momentum & MacroiPrice momentum indicators relative to key technical levels: distance from 50-Day SMA (intermediate trend), 200-Day SMA (long-term trend), 52-Week High (bullish proximity), and Beta (market sensitivity coefficient).

vs 50-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-13.5%
Above/below 50-day moving average
vs 200-Day SMAMoving Averages (SMA)A rolling average of an asset's price over a defined window — used to identify trends and momentum signals.Click for full definition →
-24.1%
Above/below 200-day moving average
vs 52-Week High52-Week HighThe highest price an asset reached in the past 52 weeks — a key reference for momentum and valuation context.Click for full definition →
66.6% from high
Distance from 52-week high
BetaBetaA measure of an asset's sensitivity to broad market movements relative to a benchmark (e.g. S&P 500).Click for full definition →
-0.64
Market sensitivity coefficient

Frequently Asked Questions & Methodology

Is Heartbeam Inc a high-risk investment?

Heartbeam Inc (BEAT.US) has an annualized volatility of 181.2% and experienced a maximum drawdown of 84.2% over the last 10 years. Its primary macro risk driver is SHV.US.

What is the 10-year return of BEAT.US?

Over the past 10 years, BEAT.US has generated a Compound Annual Growth Rate (CAGR) of -22.6%. It has had a positive return in 40% of the years measured.

Data Methodology & Trust

The risk and return information on this page is pre-calculated mathematically using daily market data spanning a 10-year period. Fundamentals (such as P/E Ratio, Market Cap, and Dividend Yield) represent trailing averages and may not immediately reflect real-time live market fluctuations. Advanced scoring models like the Piotroski F-Score and Altman Z-Score are proxies applied to publicly available trailing-twelve-month financial statements and may not account for recent off-balance-sheet events, qualitative company shifts, or sector-specific capital structures. Macroeconomic factor exposures are estimated via multivariate regression against standard market indices. This data is provided for quantitative insight and backtesting research, and should not be misconstrued as tailored financial advice.

Run a Full Backtest on Heartbeam Inc

stresstest.pro lets you simulate DCA vs Lump Sum, Monte Carlo projections, portfolio optimisation, and more — all in seconds.

Start a Free Backtest